Through the first three quarters of 2021, Nasdaq has continued to see strong listings momentum not only in the U.S. but also in its European markets. The latter of which welcomed a record 143 listings, raising a total of EUR 7.1 billion.
The decision to go public is an exciting one for any company but getting ready for the process calls for scrupulous planning. As you move forward, here are some important steps to consider for your compensation programs.
Demystifying direct listings: What a direct listing is and how does it differ from a traditional IPO? We also explore the benefits and risks to companies and investors.
Initial public offerings, or IPOs, is one acronym that almost every investors knows. But IPOs often don't start trading immediately at 9:30 am when the bell rings. Why is that?
While there are many resources available for startups preparing for an IPO, one area of the process that can be difficult to navigate is how to properly implement cybersecurity.
Is your client excited about new IPO stocks hitting the market like Robinhood (HOOD), but you’re unsure how to approach the conversation? Considering the fanfare around major IPOs, they can be hard to ignore — but it isn’t always easy to decide whether to invest in one or not.
Following on from a slower IPO arrival, shares in the popular investing app Robinhood (HOOD) have been soaring - illustrating the influence of the platform and its band of merry retail investors.
Robinhood (HOOD) will begin trading on the Nasdaq. This is the most eagerly anticipated offering of the year, for sure, but in many ways may be the most interesting for a long time. So what can traders and investors expect?
The global market for initial public offerings was off to a great start this year and is still running hot.There have been 250 IPOs priced this year, up 190.7% from last year, per renaissancecapital. Total proceeds raised are $89.0 billion, up 232.2% from last year. About
Founder SPAC, a blank check company targeting the cloud and other digital transformation sectors, filed on Monday with the SEC to raise up to $275 million in an initial public offering.
The Houston, TX-based company plans to raise $275 million by offering 27.5 million units at $
Neo Technology Acquisition, a blank check company targeting businesses in Asia and North America, filed on Monday with the SEC to raise up to $40 million. The New York, NY-based company plans to raise $40 million by offering 4 million units at $10. Each unit consists of one share
Ocean Biomedical, a preclinical biotech developing therapies for cancer, infections, and other diseases, revised the terms of its upcoming IPO on Monday.The Providence, RI-based company now plans to raise $50 million by offering 6.3 million shares at a price range of $7 to $9. Th
Nuvalent, a preclinical oncology biotech developing small molecule kinase inhibitors, announced terms for its IPO on Monday.
The Cambridge, MA-based company plans to raise $151 million by offering 8.9 million shares at a price range of $16 to $18. At the midpoint of the proposed
Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, announced terms for its IPO on Monday.The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoi
RxSight, a commercial-stage provider of post-cataract intraocular lens platform, announced terms for its IPO on Monday.
The Aliso Viejo, CA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint of the proposed ra